Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Treasury Shares (2021 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Treasury Shares for 5 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Treasury Shares rose 23.86% to $2.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 million, a 23.86% increase, with the full-year FY2025 number at $2.3 million, up 23.86% from a year prior.
  • Treasury Shares was $2.3 million for Q4 2025 at PROCEPT BioRobotics, up from $115000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.3 million in Q4 2025 to a low of $35000.0 in Q4 2021.
  • A 5-year average of $1.2 million and a median of $1.4 million in 2023 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: soared 2020.0% in 2022, then tumbled 94.05% in 2025.
  • PROCEPT BioRobotics' Treasury Shares stood at $35000.0 in 2021, then skyrocketed by 2020.0% to $742000.0 in 2022, then surged by 104.58% to $1.5 million in 2023, then rose by 24.77% to $1.9 million in 2024, then grew by 23.86% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Treasury Shares are $2.3 million (Q4 2025), $115000.0 (Q3 2025), and $2.1 million (Q2 2025).